Routine immunization in the Americas has recovered sharply, but a dangerous gap in measles vaccination coverage threatens to leave millions vulnerable to outbreaks, according to new estimates from the World Health Organization (WHO) and UNICEF. The organisations’ joint analysis, published in July 2026, reveals a paradox: while overall vaccination rates have rebounded from pandemic lows, measles immunisation—the most contagious human disease—remains below the 95% threshold required for population-level protection across much of the region.
Key takeaways
- Routine childhood immunisation coverage has rebounded in the Americas following pandemic disruptions, but remains below pre-pandemic levels in several countries
- Measles, mumps, and rubella (MMR) vaccination coverage has declined, falling below the 95% threshold needed to prevent outbreaks and maintain herd immunity
- The gap between routine immunisation recovery and measles coverage represents a critical public health vulnerability across the region
Immunisation Coverage Gap: Routine vs. Measles Protection
Population coverage by vaccination type across the Americas, 2026 estimates
Source: WHO and UNICEF, July 2026 | Georgian Medical Journal News
Pandemic recovery masks widening protection gap
Following severe disruptions during COVID-19, routine immunisation services in the Americas have shown substantial recovery, according to the joint WHO and UNICEF statement released by the Pan American Health Organization (PAHO) in July 2026. However, this recovery has not been evenly distributed across vaccines or populations, creating pockets of vulnerability that epidemiologists warn could fuel outbreaks.
The rebound in overall coverage figures masks a troubling asymmetry: while essential childhood vaccines have recovered, measles immunity—which requires sustained, high coverage to be effective—has fallen behind. This creates conditions where transmission could accelerate rapidly once the virus finds an unvaccinated cluster, a phenomenon documented in recent years across multiple regions when coverage drops below critical thresholds. See our Global Health coverage for ongoing monitoring of outbreak risks.
The critical importance of the 95% threshold
Measles is the most contagious human pathogen known, with a basic reproduction number (R₀) between 12 and 18, meaning a single infected person will typically transmit the disease to 12–18 others in an unvaccinated population. To prevent sustained transmission, population-level immunity must reach 95%, according to WHO measles fact sheets. Current PAHO and UNICEF estimates show that first-dose MMR coverage across the Americas stands below this critical threshold, with second-dose coverage even lower in most countries.
This gap is particularly concerning in countries with large, mobile populations and cross-border migration, where measles can spread rapidly. Health officials across the region acknowledge that closing this immunity gap is essential to preventing large-scale outbreaks. For detailed clinical guidance, consult our Clinical Updates section on vaccination protocols.
Measles, mumps, and rubella vaccination coverage remains below the 95% population threshold required to prevent transmission across much of the Americas, despite broader recovery in routine immunisation rates, according to WHO and UNICEF joint estimates.
— WHO and UNICEF (Pan American Health Organization, July 2026)
Implications for disease control and outbreak prevention
The current coverage gap creates a window of vulnerability that could enable rapid measles spread, particularly in densely populated urban areas and among migrant and displaced populations. Migration-related health challenges have already complicated immunisation efforts in several countries, and inconsistent coverage across borders amplifies outbreak risk. Public health officials now face the urgent task of targeting communities with low vaccination coverage to restore herd immunity before measles circulation intensifies.
Addressing this gap requires sustained funding, community engagement, and coordination across national health systems—challenges that have only intensified as resources shift toward pandemic response and other priorities. The window to prevent measles outbreaks is narrow, and every month of delayed vaccination efforts increases the probability of clusters of susceptible individuals large enough to sustain transmission chains.
What this means
Frequently asked questions
Why is 95% coverage required for measles prevention?
Measles spreads exceptionally efficiently—each infected person infects 12–18 others in an unvaccinated population. To break transmission chains, 95% of the population must be immune, either through vaccination or prior infection. Below this threshold, clusters of susceptible individuals allow the virus to circulate indefinitely. WHO estimates confirm this critical threshold globally.
What explains the gap between routine immunisation recovery and measles coverage?
Routine vaccines recovered more quickly because many governments prioritised childhood vaccination programmes during pandemic recovery. However, measles vaccination—which requires two doses and sustained supply chains—faced additional disruptions. Supply shortages, hesitancy, and decreased clinic access in certain populations created persistent gaps, particularly in second-dose coverage.
Are measles outbreaks likely if coverage remains below 95%?
Yes. Outbreaks become increasingly probable as coverage falls below 95%, and historical data shows clusters can emerge rapidly when the virus is introduced into communities with patchy immunity. Epidemiological studies document this pattern consistently across multiple regions and time periods.
The Americas now face a critical window to restore measles vaccination coverage before outbreaks become inevitable. Policymakers, clinicians, and public health officials must act urgently to identify and vaccinate remaining unprotected populations, particularly children missed during pandemic disruptions. Success requires sustained commitment, equitable resource allocation, and integration with broader immunisation strengthening efforts—investments that will protect the region from measles and other vaccine-preventable diseases for years to come.
Was this article helpful?
Related Coverage
